Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Capodanno

Showing results (421-430 of 570) with videos related to

Pageof 57
Sort By:
The American Journal of Cardiology|April 14, 2018
Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip SystemCarmelo Grasso, Antonio Popolo Rubbio, Davide Capodanno, et al.
Journal of the American College of Cardiology|May 30, 2020
Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI PatientsDavide Cao, Roxana Mehran, George Dangas, et al.
Journal of the American College of Cardiology|July 6, 2019
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art ReviewDavide Capodanno, Kurt Huber, Roxana Mehran, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 9, 2016
Impact of chronic kidney disease on outcomes after percutaneous mitral valve repair with the MitraClip system: insights from the GRASP registryYohei Ohno, Guilherme F Attizzani, Davide Capodanno, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 21, 2025
Impact of CHA<sub>2</sub>DS<sub>2</sub>-VASc Score in the Outcomes of Patients Undergoing a Simplified Pathway for Percutaneous Left Atrial Appendage ClosureClaudio Sanfilippo, Marco Frazzetto, Giuliano Costa, et al.
European Heart Journal|May 19, 2026
Aspirin vs clopidogrel in chronic coronary syndromes: a meta-analysis of ethnic differencesClaudio Laudani, Giovanni Occhipinti, Francesco Costa, et al.
European Heart Journal|December 17, 2021
Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trialsMattia Galli, Stefano Benenati, Francesco Franchi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 22, 2014
Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registryDavide Capodanno, Tommaso Gori, Holger Nef, et al.
International Journal of Cardiology|March 27, 2018
High on-treatment platelet reactivity and outcome in elderly with non ST-segment elevation acute coronary syndrome - Insight from the GEPRESS studyRoberta De Rosa, Tullio Palmerini, Stefano De Servi, et al.
JACC. Cardiovascular Interventions|February 16, 2016
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA RegistriesCorrado Tamburino, Piera Capranzano, Tommaso Gori, et al.
Pageof 57

Showing results (421-430 of 570) with videos related to

Sort By:
Pageof 57
The American Journal of Cardiology|April 14, 2018
Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip SystemCarmelo Grasso, Antonio Popolo Rubbio, Davide Capodanno, et al.
Journal of the American College of Cardiology|May 30, 2020
Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI PatientsDavide Cao, Roxana Mehran, George Dangas, et al.
Journal of the American College of Cardiology|July 6, 2019
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art ReviewDavide Capodanno, Kurt Huber, Roxana Mehran, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 9, 2016
Impact of chronic kidney disease on outcomes after percutaneous mitral valve repair with the MitraClip system: insights from the GRASP registryYohei Ohno, Guilherme F Attizzani, Davide Capodanno, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 21, 2025
Impact of CHA<sub>2</sub>DS<sub>2</sub>-VASc Score in the Outcomes of Patients Undergoing a Simplified Pathway for Percutaneous Left Atrial Appendage ClosureClaudio Sanfilippo, Marco Frazzetto, Giuliano Costa, et al.
European Heart Journal|May 19, 2026
Aspirin vs clopidogrel in chronic coronary syndromes: a meta-analysis of ethnic differencesClaudio Laudani, Giovanni Occhipinti, Francesco Costa, et al.
European Heart Journal|December 17, 2021
Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trialsMattia Galli, Stefano Benenati, Francesco Franchi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 22, 2014
Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registryDavide Capodanno, Tommaso Gori, Holger Nef, et al.
International Journal of Cardiology|March 27, 2018
High on-treatment platelet reactivity and outcome in elderly with non ST-segment elevation acute coronary syndrome - Insight from the GEPRESS studyRoberta De Rosa, Tullio Palmerini, Stefano De Servi, et al.
JACC. Cardiovascular Interventions|February 16, 2016
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA RegistriesCorrado Tamburino, Piera Capranzano, Tommaso Gori, et al.
Pageof 57